Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides?

Clinical and Experimental Immunology

Volumn 114, Issue 3, 1998, Pages 491-499

  Muller Kobold, A C ^a   Mesander, G ^a   Stegeman, C A ^a   Kallenberg, C G M ^a   Cohen Tervaert, J W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adhesion molecules; ANCA; Flow cytometry; Neutrophil activation; Sepsis; Vasculitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ANTIGEN EXPRESSION; ARTICLE; FLOW CYTOMETRY; HOST RESISTANCE; HUMAN; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; VASCULITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; SHWARTZMAN PHENOMENON;

EID: 0031736098     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00748.x     Document Type: Article

References (49)

1. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46:1-15.
2. Jennette JC, Falk RJ. Small vessel vasculitis. N Engl J Med 1997; 337:1512-23.
3. Cohen Tervaert JW, Mulder L, Stegeman C et al. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993; 52:115-120.
4. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:4115-9.
5. Charles LA, Falk RJ, Jennette JC. Reactivity of antineutrophil cytoplasmic autoantibodies with mononuclear phagocytes. J Leuk Biol 1992; 51:65-68.
6. Keogan MT, Esnault VL, Green AJ et al. Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 1992; 90:228-34.
7. Lai KN, Leung JC, Rifkin I, Lockwood CM. Effect of anti-neutrophil cytoplasm autoantibodies on the intracellular calcium concentration of human neutrophils. Lab Invest 1994; 70:152-62.
8. Mulder AH, Stegeman CA, Kallenberg CGM. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA. Clin Exp Immunol 1995; 101:227-32.
9. Johnson PA, Alexander HD, McMillan SA, Maxwell AP. Up-regulation of the granulocyte adhesion molecule Mac-1 by autoantibodies in autoimmune vasculitis. Clin Exp Immunol 1997; 107:513-9.
10. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76:301-14.
11. van Vollenhoven RF. Adhesion molecules, sex steroids, and the pathogenesis of vasculitis syndromes. Curr Opin Rheumatol 1995; 7:4-10.
12. Cohen Tervaert JW, Kallenberg CGM. The role of autoimmunity to myeloid lysosomal enzymes in the pathogenesis of vasculitis. In: Hansson GK, Libby P, eds. Immune functions of the vessel wall. Amsterdam: Harwood Academic Publishers, 1996:99-120.
13. Molad Y, Buyon J, Anderson DC et al. Intravascular neutrophil activation in systemic lupus erythematosus (SLE): dissociation between increased expression of CD11b/CD18 and diminished expression of L-selectin on neutrophils from patients with active SLE. Clin Immunol Immunopathol 1994; 71:281-6.
14. Argenbright LW, Barton RW. Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited. J Clin Invest 1992; 89:259-72.
15. Belmont HM, Buyon J, Giorno R, Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum 1994; 37:376-83.
16. Buyon JP, Shadick N, Berkman R et al. Surface expression of Gp 165/ 95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosus. Clin Immunol Immunopathol 1988; 46:141-9.
17. Muller Kobold AC, Tulleken JE, Zijlstra JG et al. Leukocyte activation in sepsis: correlations with disease state and mortality. Submitted, 1998.
18. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-92.
19. Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallengerg CGM. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996; 335:16-20.
20. Cohen Tervaert JW, Huitema MG, Hene RJ et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336:709-11.
21. Ziegler EJ, Fisher CJ Jr, Sprung CL et al. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991; 324:429-36.
22. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87:671-8.
23. Exley AR, Bacon PA, Luqmani RA et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997; 40:371-80.
24. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
25. Cohen Tervaert JW, Goldschmeding R, Elema JD et al. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990; 37:799-806.
26. Mulder AH, Broekroelofs J, Horst G et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin Exp Immunol 1994; 95:490-7.
27. Kuijpers TW, Tool AT, van der Schoot CE et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991; 78:1105-11.
28. Hamblin A, Taylor M, Bernhagen J et al. A method of preparing blood leucocytes for flow cytometry which prevents upregulation of leucocyte integrins. J Immunol Methods 1992; 146:219-28.
29. Muller Kobold AC, Kallenberg CGM, Cohen Tervaert JW. Leukocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. Br J Rheumatol 1998; 37:901-7.
30. Sladek TL, Jacobberger JW. Flow cytometric titration of retroviral expression vectors: comparison of methods for analysis of immunofluorescence histograms derived from cells expressing low antigen levels. Cytometry 1993; 14:23-31.
31. Schwarz A, Fernandez-Repollet E. Development of clinical standards for flow cytometry. Ann N Y Acad Sci 1993; 677:28-39.
32. Lundahl J, Hed J. Differences in altered expression of L-selectin and Mac-1 in monocytes and neutrophils. Inflammation 1994; 18:67-76.
33. Schleiffenbaum B, Spertini O, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992; 119:229-38.
34. Wayner EA, Garcia Pardo A, Humphries MJ et al. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 1989; 109:1321-30.
35. Kinashi T, Springer TA. Adhesion molecules in hematopoietic cells. Blood Cells 1994; 20:25-44.
36. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346:425-34.
37. Elsner J, Sach M, Knopf HP et al. Synthesis and surface expression of ICAM-1 in polymorphonuclear neutrophilic leukocytes in normal subjects and during inflammatory disease. Immunobiology 1995; 193:456-64.
38. Metzelaar MJ, Wijngaard PL, Peters PJ et al. CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991; 266:3239-45.
39. Kuroki M, Yamanaka T, Matsuo Y et al. Immunochemical analysis of carcinoembryonic antigen (CEA)-related antigens differentially localized in intracellular granules of human neutrophils. Immunol Invest 1995; 24:829-43.
40. Ducker TP, Skubitz KM. Subcellular localization of CD66, CD67, and NCA in human neutrophils. J Leukoc Biol 1992; 52:11-16.
41. Valerius T, Repp R, de Wit TP et al. Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood 1993; 82:931-39.
42. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-76.
43. Riecken B, Gutfleisch J, Schlesier M, Peter HH. Impaired granulocyte oxidative burst and decreased expression of leucocyte adhesion molecule-1 (LAM-1) in patients with Wegener's granulomatosis. Clin Exp Immunol 1994; 96:43-47.
44. Macey MG, Jiang XP, Veys P, McCarthy D, Newland AC. Expression of functional antigens on neutrophils. Effects of preparation. J Immunol Methods 1992; 149:37-42.
45. Stibenz D, Buhrer C. Down-regulation of L-selectin surface expression by various leukocyte isolation procedures. Scand J Immunol 1994; 39:59-63.
46. Haller H, Eichhorn J, Pieper K, Goebel U, Luft FC. Circulating leukocyte integrin expression in Wegener's granulomatosis. J Am Soc Nephrol 1996; 7:40-48.
47. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 1995; 86:3189-95.
48. Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC. Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 1991; 50:539-46.
49. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994; 95:244-50.